References
- Tak YJ, Lee JG, Kim YJ, et al. Serum 25-hydroxyvitamin D levels and testosterone deficiency in middle-aged Korean men: a cross-sectional study. Asian J Androl. 2015;17:324.
- Wang N, Han B, Li Q, et al. Vitamin D is associated with testosterone and hypogonadism in Chinese men: results from a cross-sectional SPECT-China study. Reprod Biol Endocrinol. 2015;13:74.
- Gutierrez-Robledo LM, Avila-Funes JA, Amieva H, et al. Association of low serum 25-hydroxyvitamin D levels with the frailty syndrome in Mexican community-dwelling elderly. Aging Male. 2016;19:58.
- Pittas AG, Chung M, Trikalinos T, et al. Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med. 2010;152:307.
- Wu PW, Rhew EY, Dyer AR, et al. 25-Hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus erythematosus. Arthritis Rheum. 2009;61:1387.
- Melamed ML, Michos ED, Post W, et al. 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008;168:1629.
- Khaw KT, Dowsett M, Folkerd E, et al. Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population study. Circulation. 2007;116:2694.
- Lee DM, Tajar A, Pye SR, et al. Association of hypogonadism with vitamin D status: the European Male Ageing study. Eur J Endocrinol. 2012;166:77.
- Caretta N, Vigili de Kreutzenberg S, Valente U, et al. Hypovitaminosis D is associated with lower urinary tract symptoms and benign prostate hyperplasia in type 2 diabetes. Andrology. 2015;3:1062.
- Zhang W, Zheng X, Wang Y, et al. Vitamin D deficiency as a potential marker of benign prostatic hyperplasia. Urology. 2016;97:212.
- Ha CD, Han TK, Lee SH, et al. Association between serum vitamin D status and metabolic syndrome in Korean young men. Med Sci Sports Exerc. 2014;46:513.
- Chung JY, Hong SH. Vitamin D status and its association with cardiometabolic risk factors in Korean adults based on a 2008–2010 Korean National Health and Nutrition Examination Survey. Nutr Res Pract. 2013;7:495.
- Parsons JK, Carter HB, Partin AW, et al. Metabolic factors associated with benign prostatic hyperplasia. J Clin Endocrinol Metab. 2006;91:2562.
- Qu X, Huang Z, Meng X, et al. Prostate volume correlates with diabetes in elderly benign prostatic hyperplasia patients. Int Urol Nephrol. 2014;46:499.
- Yeh HC, Liu CC, Lee YC, et al. Associations of the lower urinary tract symptoms with the lifestyle, prostate volume, and metabolic syndrome in the elderly males. Aging Male. 2012;15:166.
- Demir O, Akgul K, Akar Z, et al. Association between severity of lower urinary tract symptoms, erectile dysfunction and metabolic syndrome. Aging Male. 2009;12:29.
- Espinosa G, Esposito R, Kazzazi A, et al. Vitamin D and benign prostatic hyperplasia – a review. Can J Urol. 2013;20:6820.
- Crescioli C, Maggi M, Luconi M, et al. Vitamin D3 analogue inhibits keratinocyte growth factor signaling and induces apoptosis in human prostate cancer cells. Prostate. 2002;50:15.
- Kramer G, Mitteregger D, Marberger M. Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? Eur Urol. 2007;51:1202.
- Ruan L, Zhu JG, Pan C, et al. Association between single nucleotide polymorphism of vitamin D receptor gene FokI polymorphism and clinical progress of benign prostatic hyperplasia. Sci World J. 2015;2015:235895.
- Yalcinkaya S, Eren E, Eroglu M, et al. Deficiency of vitamin D and elevated aldosterone in prostate hyperplasia. Adv Clin Exp Med. 2014;23:441.
- Colli E, Rigatti P, Montorsi F, et al. BXL628, a novel vitamin D3 analog arrests prostate growth in patients with benign prostatic hyperplasia: a randomized clinical trial. Eur Urol. 2006;49:82.
- Canguven O, Talib RA, El Ansari W, et al. Vitamin D treatment improves levels of sexual hormones, metabolic parameters and erectile function in middle-aged vitamin D deficient men. Aging Male. 2017. [Epub ahead of print]. doi:10.1080/13685538.2016.1271783.
- Kinuta K, Tanaka H, Moriwake T, et al. Vitamin D is an important factor in estrogen biosynthesis of both female and male gonads. Endocrinology. 2000;141:1317.
- Blomberg Jensen M, Nielsen JE, Jorgensen A, et al. Vitamin D receptor and vitamin D metabolizing enzymes are expressed in the human male reproductive tract. Hum Reprod. 2010;25:1303.
- Glueck CJ, Jetty V, Rothschild M, et al. Associations between serum 25-hydroxyvitamin D and lipids, lipoprotein cholesterols, and homocysteine. N Am J Med Sci. 2016;8:284.